Tonix Pharma (NASDAQ: TNXP) reported Q4 EPS of ($9.77), $5.86 worse than the analyst estimate of ($3.91). Revenue for the quarter came in at $2.58 million versus the consensus estimate of $3.2 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.